{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:13:30Z","timestamp":1779185610634,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS201428"],"award-info":[{"award-number":["SYS201428"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"crossref","award":["SYS2019093"],"award-info":[{"award-number":["SYS2019093"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11239-020-02306-1","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T15:02:49Z","timestamp":1602255769000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Zhangfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoshuai","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-9662","authenticated-orcid":false,"given":"Xing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"2306_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.STR.0000199138.73365.b3","volume":"37","author":"M Vargas","year":"2006","unstructured":"Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F, Planas AM, Mensa J, Chamorro A (2006) Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 37:461\u2013465. https:\/\/doi.org\/10.1161\/01.STR.0000199138.73365.b3","journal-title":"Stroke"},{"key":"2306_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/01.STR.0000063373.70993.CD","volume":"34","author":"R Hilker","year":"2003","unstructured":"Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD (2003) Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 34:975\u2013981. https:\/\/doi.org\/10.1161\/01.STR.0000063373.70993.CD","journal-title":"Stroke"},{"key":"2306_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2018.03.019","volume":"70","author":"R Shim","year":"2018","unstructured":"Shim R, Wong CHY (2018) Complex interplay of multiple biological systems that contribute to post-stroke infections. Brain Behav Immun 70:10\u201320. https:\/\/doi.org\/10.1016\/j.bbi.2018.03.019","journal-title":"Brain Behav Immun"},{"key":"2306_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.neuroscience.2008.07.044","volume":"158","author":"J Klehmet","year":"2009","unstructured":"Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, Meisel A, Meisel C (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158:1184\u20131193. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.07.044","journal-title":"Neuroscience"},{"key":"2306_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264\u2013274. https:\/\/doi.org\/10.1038\/nri2956","journal-title":"Nat Rev Immunol"},{"key":"2306_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/archinternmed.2009.42","volume":"169","author":"E Blasco-Colmenares","year":"2009","unstructured":"Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N (2009) Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 169:788\u2013796. https:\/\/doi.org\/10.1001\/archinternmed.2009.42","journal-title":"Arch Intern Med"},{"key":"2306_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/ene.13801","volume":"26","author":"TJ Kim","year":"2019","unstructured":"Kim TJ, Lee JS, Kang MK, Nam KW, Lee CH, Mo H, Jeong HY, Yoon BW, Ko SB (2019) Clopidogrel may decrease the risk of post-stroke infection after ischaemic stroke. Eur J Neurol 26:261\u2013267. https:\/\/doi.org\/10.1111\/ene.13801","journal-title":"Eur J Neurol"},{"key":"2306_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/1747493017694391","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu M, Pu C (2017) 2014 Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack. Int J Stroke 12:302\u2013320. https:\/\/doi.org\/10.1177\/1747493017694391","journal-title":"Int J Stroke"},{"key":"2306_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1160\/TH14-11-0943","volume":"114","author":"WC Schrottmaier","year":"2015","unstructured":"Schrottmaier WC, Kral JB, Badrnya S, Assinger A (2015) Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb Haemost 114:478\u2013489. https:\/\/doi.org\/10.1160\/TH14-11-0943","journal-title":"Thromb Haemost"},{"key":"2306_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1474-4422(08)70061-9","volume":"7","author":"HC Emsley","year":"2008","unstructured":"Emsley HC, Hopkins SJ (2008) Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 7:341\u2013353. https:\/\/doi.org\/10.1016\/S1474-4422(08)70061-9","journal-title":"Lancet Neurol"},{"key":"2306_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1160\/TH14-12-1068","volume":"114","author":"MR Thomas","year":"2015","unstructured":"Thomas MR, Storey RF (2015) Effect of P2Y12 inhibitors on inflammation and immunity. Thromb Haemost 114:490\u2013497. https:\/\/doi.org\/10.1160\/TH14-12-1068","journal-title":"Thromb Haemost"},{"key":"2306_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fneur.2017.00006","volume":"8","author":"CH Wong","year":"2017","unstructured":"Wong CH, Jenne CN, Tam PP, L\u00e9ger C, Venegas A, Ryckborst K, Hill MD, Kubes P (2017) Prolonged activation of invariant natural killer T cells and TH2-skewed immunity in stroke patients. Front Neurol 8:6. https:\/\/doi.org\/10.3389\/fneur.2017.00006","journal-title":"Front Neurol"},{"key":"2306_CR13","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1161\/STROKEAHA.109.557967","volume":"40","author":"A Hug","year":"2009","unstructured":"Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, Auffarth G, Liesz A, Veltkamp R (2009) Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 40:3226\u20133232. https:\/\/doi.org\/10.1161\/STROKEAHA.109.557967","journal-title":"Stroke"},{"key":"2306_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa065","author":"H Long","year":"2020","unstructured":"Long H, Feng Q, Tsoi MF, Fei Y, Cheung BMY (2020) Risk of infections in patients treated with ticagrelor versus clopidogrel: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa065","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2306_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jacc.2014.06.1170","volume":"64","author":"DJ Angiolillo","year":"2014","unstructured":"Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F, Ueno M, Darlington A, Desai B, Moser BA, Sugidachi A, Guzman LA, Bass TA (2014) Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease. J Am Coll Cardiol 64:1005\u20131014. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1170","journal-title":"J Am Coll Cardiol"},{"key":"2306_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","volume":"52","author":"L Ang","year":"2008","unstructured":"Ang L, Palakodeti V, Khalid A, Tsimikas S, Idrees Z, Tran P, Clopton P, Zafar N, Bromberg-Marin G, Keramati S, Mahmud E (2008) Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coll Cardiol 52:1052\u20131059. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.054","journal-title":"J Am Coll Cardiol"},{"key":"2306_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc08-2064","volume":"32","author":"DJ Angiolillo","year":"2009","unstructured":"Angiolillo DJ (2009) Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions. Diabetes Care 32:531\u2013540. https:\/\/doi.org\/10.2337\/dc08-2064","journal-title":"Diabetes Care"},{"key":"2306_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/s0002-9149(02)02567-5","volume":"90","author":"DL Bhatt","year":"2002","unstructured":"Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ (2002) Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 90:625\u2013628. https:\/\/doi.org\/10.1016\/s0002-9149(02)02567-5","journal-title":"Am J Cardiol"},{"key":"2306_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jacc.2014.07.003","volume":"64","author":"MJ Price","year":"2014","unstructured":"Price MJ (2014) Diabetes mellitus and clopidogrel response variability. J Am Coll Cardiol 64:1015\u20131018. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.003","journal-title":"J Am Coll Cardiol"},{"key":"2306_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cns.12173","volume":"20","author":"YJ Lin","year":"2014","unstructured":"Lin YJ, Li JW, Zhang MJ, Qian L, Yang WJ, Zhang CL, Shao Y, Zhang Y, Huang YJ, Xu Y (2014) The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment. CNS Neurosci Ther 20:125\u2013130. https:\/\/doi.org\/10.1111\/cns.12173","journal-title":"CNS Neurosci Ther"},{"key":"2306_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/STROKEAHA.113.000823","volume":"44","author":"DM Jia","year":"2013","unstructured":"Jia DM, Chen ZB, Zhang MJ, Yang WJ, Jin JL, Xia YQ, Zhang CL, Shao Y, Chen C, Xu Y (2013) CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Stroke 44:1717\u20131719. https:\/\/doi.org\/10.1161\/STROKEAHA.113.000823","journal-title":"Stroke"},{"key":"2306_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2014.11.037","volume":"747","author":"LN Qiu","year":"2015","unstructured":"Qiu LN, Sun Y, Wang L, Han RF, Xia XS, Liu J, Li X (2015) Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Eur J Pharmacol 747:29\u201335. https:\/\/doi.org\/10.1016\/j.ejphar.2014.11.037","journal-title":"Eur J Pharmacol"},{"key":"2306_CR23","doi-asserted-by":"publisher","first-page":"e001652","DOI":"10.1161\/JAHA.114.001652","volume":"4","author":"CW McDonough","year":"2015","unstructured":"McDonough CW, McClure LA, Mitchell BD, Gong Y, Horenstein RB, Lewis JP, Field TS, Talbert RL, Benavente OR, Johnson JA, Shuldiner AR (2015) CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. J Am Heart Assoc 4:e001652. https:\/\/doi.org\/10.1161\/JAHA.114.001652","journal-title":"J Am Heart Assoc"},{"key":"2306_CR24","unstructured":"LABEL (2019) CLOPIDOGREL\u2014clopidogrel bisulfate tablet, film coated. U.S. National Institutes of Health, National Library of Medicine. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=edae8df1-caf9-ff72-1304-5ae8b355f8e7. Accessed 27Dec 2019"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02306-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:48:14Z","timestamp":1633848494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02306-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2306"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02306-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"1 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.<b>Ethics approval<\/b> The Institutional Review Board at Affiliated Suzhou Hospital of Nanjing Medical University approved this study with a waiver of informed consent (Institutional Review Board Number: KL901057).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}